Michela Ansuinelli | Ricerc@Sapienza

Publications

Title	Published on	Year
Immune-hematologic monitoring after allogeneic stem cell transplantation: unicentric prospective study on 104 patients.	BONE MARROW TRANSPLANTATION	2018
Multiparametric Magnetic Resonance Enterography for the Diagnosis and Staging of Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation	BONE MARROW TRANSPLANTATION	2018
. BEAM vs FEAM conditioning: retrospective study in lymphoma patients undergoing autologous stem cell transplant.	BONE MARROW TRANSPLANTATION	2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)	THE ONCOLOGIST	2018
Primary mediastinal large B-cell lymphoma	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors	HEMATOLOGICAL ONCOLOGY	2017
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?	EXPERT REVIEW OF HEMATOLOGY	2017
EFFICACY, SAFETY AND COST ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP	HAEMATOLOGICA	2017
Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results	BLOOD CANCER JOURNAL	2016
CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTER ANALYSIS OF THE RISK FACTORS AND THE IMPACT OF CNS PROPHYLAXIS IN THE RITUXIMAB ERA	21st Congress of the European-Hematology-AssociationHAEMATOLOGICA	2016